Turning Point Therapeutics Inc (TPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Operating Expenses | 6,129 | 5,172 | 4,860 | 0 |
| Operating Income | -6,129 | -5,172 | -4,860 | N/A |
| Other Income | 132 | 135 | 127 | 0 |
| Pre-tax Income | -5,997 | -5,037 | -4,733 | 0 |
| Net Income Continuous | -5,997 | -5,037 | -4,733 | N/A |
| Net Income | $-5,997 | $-5,037 | $-4,733 | $N/A |
| EPS Basic Total Ops | -1.77 | -1.49 | -1.41 | N/A |
| EPS Basic Continuous Ops | -1.77 | -1.49 | -1.40 | N/A |
| EPS Diluted Total Ops | -1.77 | -1.49 | -1.41 | N/A |
| EPS Diluted Continuous Ops | -1.77 | -1.49 | -1.40 | N/A |
| EBITDA(a) | $-6,104 | $-5,151 | $-4,842 | $N/A |